IRCT20171113037434N1已完成2 期
Investigation of the efficacy of dual anti-platelet therapy compared to aspirin on graft patency and peri-operative bleeding in coronary artery bypass graft surgery
Sanofi-Aventis Pharmaceutical Company0 个研究点目标入组 216 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 216
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Patients Age =18 year-old
- •Candidate for elective coronary bypass graft surgery
排除标准
- •1)Concomitant valve surgeries
- •2)Concomitant Aortic surgery
- •3)Redo-CABGs
- •4) Patients who don't take Aspirin at least 48 hours before surgery
- •5)Clopidogrel use within 5 days before CABG
- •6)Any condition with increased bleeding risk that precludes dual anti-platelet therapy
- •7)Significant bleeding in the first 4 hours after surgery
研究者
相似试验
已完成
不适用
Binary investigation on the Effects of antiplatelet agents post-PCI: the Necessity of considering vascular Endothelial Function in post coronary Intervention pharmacotherapyAngina pectoris and myocardial infarctionJPRN-UMIN000004065Showa University Fujigaoka Hospital80
招募中
不适用
Changes in predictive capacity when adding Ticagrelor and Clopidogrel to an existing allogeneic bloodtransfuion prediction model for cardiac surgery.NL-OMON22097Department of Cardiac Surgery and Department of Anesthesia Amsterdam UMC3,500
尚未招募
Unknown
An observation study to evaluate safety and efficacy of antiplatelet drugs in patients after percutaneous coronary intervention.CTRI/2023/10/059339Pragya Hangma Subba
已完成
不适用
oborI dual antiplatelet therapy as aPPropriate duratiON (NIPPON)Coronary Artery DiseaseJPRN-UMIN000006698PO Associations for Establishment of Evidence in Interventions4,598
终止
不适用
Comparison of the effect of an anti-platelet intervention with Ticagrelor versus placebo on participants with asymptomatic elevations in troponin TACTRN12614000189628Professor Derek Chew420